Key result
General anesthesia using thiopental, remifentanil, sevoflurane, and sugammadex was safely administered without triggering malignant ventricular arrhythmias in a patient with Brugada syndrome.
Why the study?
Anaesthetic management in Brugada syndrome is challenging because many perioperative drugs can trigger fatal cardiac arrhythmias.
Case Report (n=1)
No
Careful preoperative evaluation, avoidance of arrhythmia-triggering drugs, and prophylactic defibrillator readiness allow for safe general anaesthesia in patients with Brugada syndrome.
Answers are grounded in this paper and cite their sources.
Supports anesthetic safety in Brugada syndrome; leaves open broader applicability pending prospective data.
We report the case of a 52-year-old female diagnosed with Brugada syndrome (BrS) scheduled to undergo right total knee arthroplasty. General anaesthesia was induced and maintained with thiopental intravenous sodium + remifentanil and sevoflurane + remifentanil infusion, respectively. Rocuronium bromide was used as the muscle relaxant. The defibrillator was ready for use with the electrodes on the patient. Sugammadex was used for muscle relaxant antagonization. Postoperative analgesia was provided by intermittent morphine HCL via an epidural catheter, intravenous patient-controlled analgesia (Meperidine), and intravenous tenoxicam. The patient was discharged on the 6th day without any problem. Anaesthetic management of patients with BrS is challenging for anaesthesiologists, because fatal cardiac arrhythmias can be triggered by many drugs commonly used in the perioperative period such as bupivacaine, lidocaine, neostigmine, propofol, succinylcholine, ketamine, and tramadol. In these cases, a detailed preoperative evaluation including family history, avoidance of drugs triggering arrhythmia, taking precautions against arrhythmia, and using the agents that are reported to be safe are essential for patient safety.
No takes yet. Share an insight, caveat, or question.
Tuncalı et al. (2020) conducted a case report in Brugada syndrome (n=1). General anaesthesia (thiopental, remifentanil, sevoflurane, sugammadex) was evaluated on Occurrence of ventricular arrhythmia or complications. General anesthesia using thiopental, remifentanil, sevoflurane, and sugammadex was safely administered without triggering malignant ventricular arrhythmias in a patient with Brugada syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: